GEN3017

· Genmab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN3017, covering 2025-09-23 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma [Phase 1, Phase 2]